GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) » Definitions » Ending Cash Position

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) Ending Cash Position : E£66 Mil (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Ending Cash Position?

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Ending Cash Position for the quarter that ended in Mar. 2024 was E£66 Mil.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's quarterly Ending Cash Position declined from Sep. 2023 (E£60 Mil) to Dec. 2023 (E£52 Mil) but then increased from Dec. 2023 (E£52 Mil) to Mar. 2024 (E£66 Mil).

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's annual Ending Cash Position increased from Dec. 2021 (E£14 Mil) to Dec. 2022 (E£66 Mil) but then declined from Dec. 2022 (E£66 Mil) to Dec. 2023 (E£52 Mil).


Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Ending Cash Position Historical Data

The historical data trend for Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Ending Cash Position Chart

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial 53.46 12.63 13.89 66.40 51.95

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 76.17 59.43 60.14 51.95 66.19

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=19.58+32.373
=52

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=51.954+14.236
=66


Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) Business Description

Traded in Other Exchanges
N/A
Address
No. 5 Second Industrial Zone, Sixth of October City, Giza, EGY
Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents is a pharmaceutical company. It is engaged in the manufacture and sale of branded generic pharmaceutical products nutraceuticals, cosmeceuticals, food supplements, medical devices, and veterinary products. The firm is engaged in therapeutic areas namely systemic anti-infectives, alimentary tract and metabolism, genitourinary system and sex hormones, cardiovascular system, nervous system, and blood and blood-forming organs.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) Headlines

No Headlines